IL-6Ra in Smooth Muscle Cells Protects against - and Hypoxia-induced Pulmonary Hypertension.
作者信息
Mickael Claudia, Kumar Rahul, Hernandez-Saavedra Daniel, Kassa Biruk, Sanders Linda, Koyanagi Dan, Gu Sue, Lee Michael H, Tuder Rubin M, Graham Brian B
机构信息
1 University of Colorado Anschutz Medical Campus Aurora, Colorado.
出版信息
Am J Respir Cell Mol Biol. 2019 Jul;61(1):123-126. doi: 10.1165/rcmb.2018-0277LE.
Abstract
摘要
相似文献
1
IL-6Ra in Smooth Muscle Cells Protects against - and Hypoxia-induced Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2019 Jul;61(1):123-126. doi: 10.1165/rcmb.2018-0277LE.
2
TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension.
Nat Commun. 2017 May 30;8:15494. doi: 10.1038/ncomms15494.
3
Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.
Am J Respir Cell Mol Biol. 2016 Dec;55(6):779-791. doi: 10.1165/rcmb.2015-0388OC.
4
IL-33 Initiates Vascular Remodelling in Hypoxic Pulmonary Hypertension by up-Regulating HIF-1α and VEGF Expression in Vascular Endothelial Cells.
EBioMedicine. 2018 Jul;33:196-210. doi: 10.1016/j.ebiom.2018.06.003. Epub 2018 Jun 18.
5
Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells.
Am J Respir Cell Mol Biol. 2011 Jan;44(1):66-73. doi: 10.1165/rcmb.2008-0442OC. Epub 2010 Feb 16.
6
Sirtuin 3 deficiency does not augment hypoxia-induced pulmonary hypertension.
Am J Respir Cell Mol Biol. 2013 Dec;49(6):885-91. doi: 10.1165/rcmb.2013-0191OC.
7
Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1972-9. doi: 10.1161/ATVBAHA.116.307900. Epub 2016 Aug 4.
8
Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Circulation. 2018 Aug 7;138(6):600-623. doi: 10.1161/CIRCULATIONAHA.117.033113.
9
PAR-2 inhibition reverses experimental pulmonary hypertension.
Circ Res. 2012 Apr 27;110(9):1179-91. doi: 10.1161/CIRCRESAHA.111.257568. Epub 2012 Mar 29.
10
Notch activation of Ca-sensing receptor mediates hypoxia-induced pulmonary hypertension.
Hypertens Res. 2017 Feb;40(2):117-129. doi: 10.1038/hr.2016.118. Epub 2016 Sep 1.
引用本文的文献
1
IL-6/gp130 signaling in CD4 T cells drives the pathogenesis of pulmonary hypertension.
Proc Natl Acad Sci U S A. 2024 Apr 16;121(16):e2315123121. doi: 10.1073/pnas.2315123121. Epub 2024 Apr 11.
2
Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases: A Comprehensive Review.
Trop Med Infect Dis. 2024 Jan 4;9(1):13. doi: 10.3390/tropicalmed9010013.
3
HIV and Schistosoma Co-Exposure Leads to Exacerbated Pulmonary Endothelial Remodeling and Dysfunction Associated with Altered Cytokine Landscape.
Cells. 2022 Aug 4;11(15):2414. doi: 10.3390/cells11152414.
4
Interleukin-6 mediates neutrophil mobilization from bone marrow in pulmonary hypertension.
Cell Mol Immunol. 2021 Feb;18(2):374-384. doi: 10.1038/s41423-020-00608-1. Epub 2021 Jan 8.
5
Schistosomiasis Pulmonary Arterial Hypertension.
Front Immunol. 2020 Dec 10;11:608883. doi: 10.3389/fimmu.2020.608883. eCollection 2020.
本文引用的文献
1
Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension.
J Clin Invest. 2018 May 1;128(5):1956-1970. doi: 10.1172/JCI96462. Epub 2018 Apr 9.
2
Clinical trial protocol for TRANSFORM-UK: A therapeutic open-label study of tocilizumab in the treatment of pulmonary arterial hypertension.
Pulm Circ. 2018 Jan-Mar;8(1):2045893217735820. doi: 10.1177/2045893217735820. Epub 2017 Sep 28.
3
TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension.
Nat Commun. 2017 May 30;8:15494. doi: 10.1038/ncomms15494.
4
Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex.
J Biol Chem. 2015 Nov 6;290(45):26943-26953. doi: 10.1074/jbc.M115.682138. Epub 2015 Sep 11.
5
The Causal Role of IL-4 and IL-13 in Schistosoma mansoni Pulmonary Hypertension.
Am J Respir Crit Care Med. 2015 Oct 15;192(8):998-1008. doi: 10.1164/rccm.201410-1820OC.
6
Enhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damage.
Cytokine. 2015 Dec;76(2):187-192. doi: 10.1016/j.cyto.2015.06.018. Epub 2015 Jul 9.
7
Protective role of IL-6 in vascular remodeling in Schistosoma pulmonary hypertension.
Am J Respir Cell Mol Biol. 2013 Dec;49(6):951-9. doi: 10.1165/rcmb.2012-0532OC.
8
The ubiquitous interleukin-6: a time for reappraisal.
Cardiovasc Diabetol. 2010 Oct 11;9:62. doi: 10.1186/1475-2840-9-62.
9
Role for interleukin-6 in COPD-related pulmonary hypertension.
Chest. 2009 Sep;136(3):678-687. doi: 10.1378/chest.08-2420. Epub 2009 Apr 6.
10
Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice.
Respir Res. 2009 Jan 27;10(1):6. doi: 10.1186/1465-9921-10-6.
Zotero 插件